Quick Answer
BALCHEM CORP reported R&D Expense of $18.51 million for fiscal year 2025.
BALCHEM CORP R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $18.51M | +10.2% |
| 2024 | $16.79M | +11.6% |
| 2023 | $15.05M | +23.4% |
| 2022 | $12.19M | -9.9% |
| 2021 | $13.52M | +30.9% |
| 2020 | $10.33M | -9.2% |
| 2019 | $11.38M | -1.9% |
| 2018 | $11.59M | +24.6% |
| 2017 | $9.30M | +27.0% |
| 2016 | $7.33M | +22.3% |
| 2015 | $5.99M | +24.5% |
| 2014 | $4.81M | +32.8% |
| 2013 | $3.62M | +5.8% |
| 2012 | $3.42M | +18.4% |
| 2011 | $2.89M | -9.4% |
| 2010 | $3.19M | -3.3% |
| 2009 | $3.30M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $4.50M | +3.9% | +4.6% |
| June 30, 2025 | $4.30M | +11.6% | -7.8% |
| March 31, 2025 | $4.66M | +13.7% | +7.7% |
| September 30, 2024 | $4.33M | +11.9% | +12.3% |
| June 30, 2024 | $3.85M | +1.6% | -6.0% |
| March 31, 2024 | $4.10M | +18.8% | +6.0% |
| September 30, 2023 | $3.87M | +29.1% | +1.9% |
| June 30, 2023 | $3.79M | +29.9% | +10.0% |
- BALCHEM CORP showed an increase of +10.2% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2025 period, BALCHEM CORP’s r&d expense has grown by 461.2% (from $3.30 million to $18.51 million).
- The most recent figure is from BALCHEM CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 20, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: